EUR 102.1
(0.79%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 828.1 Million EUR | 1.31% |
2022 | 811.9 Million EUR | -17.3% |
2021 | 977.8 Million EUR | 26.78% |
2020 | 747.7 Million EUR | 44.8% |
2019 | 548.2 Million EUR | 3.7% |
2018 | 508.9 Million EUR | 9.31% |
2017 | 445.5 Million EUR | 8.27% |
2016 | 416.9 Million EUR | 14.27% |
2015 | 383.9 Million EUR | 15.35% |
2014 | 307.5 Million EUR | -3.37% |
2013 | 344.4 Million EUR | 4.02% |
2012 | 331.1 Million EUR | -3.5% |
2011 | 327.1 Million EUR | 3.06% |
2010 | 332.9 Million EUR | 26.1% |
2009 | 264 Million EUR | 2.33% |
2008 | 256.7 Million EUR | -1.6% |
2007 | 251.9 Million EUR | 26.12% |
2006 | 214.5 Million EUR | -1.14% |
2005 | 213.9 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 404.3 Million EUR | 0.0% |
2023 Q2 | 373.6 Million EUR | 0.0% |
2023 FY | - EUR | 1.31% |
2023 Q4 | 421.5 Million EUR | 0.0% |
2022 Q4 | 426.6 Million EUR | 0.0% |
2022 Q2 | 390.8 Million EUR | 0.0% |
2022 FY | - EUR | -17.3% |
2021 FY | - EUR | 26.78% |
2021 Q4 | 536.4 Million EUR | 0.0% |
2021 Q2 | 451.1 Million EUR | 0.0% |
2020 Q2 | 325.3 Million EUR | 0.0% |
2020 Q4 | 454.2 Million EUR | 0.0% |
2020 FY | - EUR | 44.8% |
2019 Q2 | 266.5 Million EUR | 0.0% |
2019 FY | - EUR | 3.7% |
2019 Q4 | 271.8 Million EUR | 0.0% |
2018 Q2 | 258.39 Million EUR | 0.0% |
2018 FY | - EUR | 9.31% |
2018 Q4 | 260.8 Million EUR | 0.0% |
2017 Q2 | 252 Million EUR | 0.0% |
2017 FY | - EUR | 8.27% |
2017 Q4 | 223 Million EUR | 0.0% |
2016 Q4 | 225.6 Million EUR | 0.0% |
2016 Q2 | 213.1 Million EUR | 0.0% |
2016 FY | - EUR | 14.27% |
2015 FY | - EUR | 15.35% |
2015 Q4 | 205.1 Million EUR | 0.0% |
2015 Q2 | 178.8 Million EUR | 0.0% |
2014 Q2 | 136.2 Million EUR | 0.0% |
2014 FY | - EUR | -3.37% |
2014 Q4 | 196.6 Million EUR | 0.0% |
2013 Q4 | 175.5 Million EUR | 0.0% |
2013 Q2 | 168.9 Million EUR | 0.0% |
2013 FY | - EUR | 4.02% |
2012 Q1 | 57.12 Million EUR | 0.0% |
2012 Q3 | 57.12 Million EUR | 0.0% |
2012 Q2 | - EUR | -100.0% |
2012 Q4 | - EUR | -100.0% |
2012 FY | - EUR | -3.5% |
2011 Q1 | 60.55 Million EUR | 0.0% |
2011 Q4 | - EUR | -100.0% |
2011 FY | - EUR | 3.06% |
2011 Q3 | 60.55 Million EUR | 0.0% |
2011 Q2 | - EUR | -100.0% |
2010 Q1 | 61.15 Million EUR | 0.0% |
2010 Q3 | 61.15 Million EUR | 0.0% |
2010 FY | - EUR | 26.1% |
2010 Q4 | - EUR | -100.0% |
2010 Q2 | - EUR | -100.0% |
2009 FY | - EUR | 2.33% |
2009 Q3 | 51.27 Million EUR | 0.0% |
2009 Q4 | - EUR | -100.0% |
2009 Q1 | 51.27 Million EUR | 11.47% |
2009 Q2 | 51.27 Million EUR | 0.0% |
2008 Q1 | 46 Million EUR | 20.1% |
2008 Q4 | 46 Million EUR | 0.0% |
2008 Q3 | 46 Million EUR | 0.0% |
2008 Q2 | 46 Million EUR | 0.0% |
2008 FY | - EUR | -1.6% |
2007 Q1 | 38.3 Million EUR | 0.86% |
2007 Q4 | 38.3 Million EUR | 0.0% |
2007 Q3 | 38.3 Million EUR | 0.0% |
2007 Q2 | 38.3 Million EUR | 0.0% |
2007 FY | - EUR | 26.12% |
2006 Q4 | 37.97 Million EUR | 0.0% |
2006 FY | - EUR | -1.14% |
2006 Q1 | 37.97 Million EUR | 9.68% |
2006 Q2 | 37.97 Million EUR | 0.0% |
2006 Q3 | 37.97 Million EUR | 0.0% |
2005 FY | - EUR | 0.0% |
2005 Q3 | 34.62 Million EUR | 0.0% |
2005 Q2 | 34.62 Million EUR | 0.0% |
2005 Q4 | 34.62 Million EUR | 0.0% |
2005 Q1 | 34.62 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Biosynex SA | -10.18 Million EUR | 8231.383% |
Predilife S.A. | -3.82 Million EUR | 21771.691% |
Eurofins Scientific SE | 1.2 Billion EUR | 31.329% |
Lumibird SA | 27.3 Million EUR | -2932.334% |